GC Green Cross MS Achieves $20 Million in COVID-19 Antigen Test Kit Exports to Europe

[Asia Economy, Reporter Cho Hyunui] GC Green Cross MS announced on the 24th that its COVID-19 antigen test kit has achieved $20 million in export sales to the European market just over a month after starting exports.

The company's antigen test kit, 'GENEDIA W COVID-19 Ag,' utilizes antigen-antibody binding reactions to diagnose COVID-19 infection on-site within 10 minutes. Using sputum samples, it allows for the naked-eye confirmation of early-stage COVID-19 infection without the need for specialized equipment.

The company explained that, along with its recently export-approved fluorescent immunoassay antigen test kit, additional contracts are being made with countries such as Italy and Hungary. As a result, exports are expected to further increase, particularly centered on Europe.

An Eunok, CEO of GC Green Cross MS, stated, "We expect that demand for antigen test kits will continue in the global market until the first half of next year, when vaccines are anticipated to be supplied in large quantities."

This content was produced with the assistance of AI translation services.